Author:
Zhou Na,Qian Qi,Qi Pengcheng,Zhao Jie,Wang Chunying,Wang Qiao
Funder
National Natural Science Foundation of China
The Ministry of Education Key Project of Science and Technology Foundation of China
Hundreds of Innovative Talents Project of Hebei Education Department of China, and the Natural Science Foundation of Hebei Province of China
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry
Reference25 articles.
1. Müller L, Mauthe RJ, Riley CM et al (2006) A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regul Toxicol Pharm 44:198–211
2. ICH (2002) Impurities in new drug substances Q3A (R1), testing of new drug substances and products Q3a (R1). In: International conference on harmonization. IFPMA, Geneva
3. Ahuja S, Ashman J (1990) Terbutaline sulfate. Anal Profiles Drug Subst 19:601–605
4. World Anti-Doping Agency (WADA) The 2015 prohibited list.
http://www.wada-ama.org
5. Faiyazuddin MD, Rauf A, Ahmad N et al (2011) A validated HPTLC method for determination of terbutaline sulfate in biological samples, Application to pharmacokinetic study. Saudi Pharm J 19:185–191
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献